BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32512379)

  • 1. Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data.
    Aguilera-Diaz A; Larrayoz MJ; Palomino-Echeverría S; Vazquez I; Ariceta B; Mañú A; Blasco-Iturri Z; Bernal Del Castillo T; Olivares Salaverri M; Olave Rubio MT; Rifon-Roca J; Alfonso-Pierola A; Prosper F; Fernandez-Mercado M; Calasanz MJ
    Leuk Res; 2020 Aug; 95():106386. PubMed ID: 32512379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
    Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
    Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ line predisposition to myeloid malignancies appearing in adulthood.
    Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
    Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms.
    Sahajpal NS; Mondal AK; Ananth S; Njau A; Ahluwalia P; Jones K; Ahluwalia M; Okechukwu N; Savage NM; Kota V; Rojiani AM; Kolhe R
    PLoS One; 2020; 15(10):e0240976. PubMed ID: 33075099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation sequencing in therapy-related myeloid neoplasms compared to
    Claerhout H; Vranckx H; Lierman E; Michaux L; Boeckx N
    Acta Clin Belg; 2022 Jun; 77(3):658-663. PubMed ID: 34197279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
    Carraway HE; LaFramboise T
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic predisposition to pediatric myeloid malignancies].
    Muramatsu H
    Rinsho Ketsueki; 2016 Jun; 57(6):730-5. PubMed ID: 27384852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer predisposition syndromes associated with myeloid malignancy.
    Quinn E; Nichols KE
    Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I diagnose myeloid neoplasms with germline predisposition.
    Patel N; Calvo KR
    Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular correlates of somatic and germline
    Badar T; Nanaa A; Foran JM; Viswanatha D; Al-Kali A; Lasho T; Finke C; Alkhateeb HB; He R; Gangat N; Shah M; Tefferi A; Mangaonkar AA; Litzow MR; Ongie LJ; Chlon T; Ferrer A; Patnaik MM
    Haematologica; 2023 Nov; 108(11):3033-3043. PubMed ID: 37199125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare germline variant contributions to myeloid malignancy susceptibility.
    Li ST; Wang J; Wei R; Shi R; Adema V; Nagata Y; Kerr CM; Kuzmanovic T; Przychodzen B; Sole F; Maciejewski JP; LaFramboise T
    Leukemia; 2020 Jun; 34(6):1675-1678. PubMed ID: 31911633
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
    Yang F; Long N; Anekpuritanang T; Bottomly D; Savage JC; Lee T; Solis-Ruiz J; Borate U; Wilmot B; Tognon C; Bock AM; Pollyea DA; Radhakrishnan S; Radhakrishnan S; Patel P; Collins RH; Tantravahi S; Deininger MW; Fan G; Druker B; Shinde U; Tyner JW; Press RD; McWeeney S; Agarwal A
    Blood; 2022 Feb; 139(8):1208-1221. PubMed ID: 34482403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
    Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
    BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid neoplasms with germline DDX41 mutation.
    Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
    Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid Neoplasms with Germline Predisposition.
    Geyer JT
    Pathobiology; 2019; 86(1):53-61. PubMed ID: 30048985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
    Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
    Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.